Suppr超能文献

袢利尿剂的耳毒性作用及机制。

Ototoxic effects and mechanisms of loop diuretics.

作者信息

Ding Dalian, Liu Hong, Qi Weidong, Jiang Haiyan, Li Yongqi, Wu Xuewen, Sun Hong, Gross Kenneth, Salvi Richard

机构信息

Center for Hearing and Deafness, 137 Cary Hall, University at Buffalo, Buffalo, NY 14214, United States.

Department of Otolaryngology, Xiangya Hospital of Central South University, Changsha 410008, China.

出版信息

J Otol. 2016 Dec;11(4):145-156. doi: 10.1016/j.joto.2016.10.001. Epub 2016 Oct 27.

Abstract

Over the past two decades considerable progress has been made in understanding the ototoxic effects and mechanisms underlying loop diuretics. As typical representative of loop diuretics ethacrynic acid or furosemide only induces temporary hearing loss, but rarely permanent deafness unless applied in severe acute or chronic renal failure or with other ototoxic drugs. Loop diuretic induce unique pathological changes in the cochlea such as formation of edematous spaces in the epithelium of the stria vascularis, which leads to rapid decrease of the endolymphatic potential and eventual loss of the cochlear microphonic potential, summating potential, and compound action potential. Loop diuretics interfere with strial adenylate cyclase and Na+/K+-ATPase and inhibit the Na-K-2Cl cotransporter in the stria vascularis, however recent reports indicate that one of the earliest effects is to abolish blood flow in the vessels supplying the lateral wall. Since ethacrynic acid does not damage the stria vascularis in vitro, the changes in Na+/K+-ATPase and Na-K-2Cl seen may be secondary effects results from strial ischemia and anoxia. Recent observations showing that renin is present in pericytes surrounding stria arterioles suggest that diuretics may induce local vasoconstriction by renin secretion and angiotensin formation. The tight junctions in the blood-cochlea barrier prevent toxic molecules and pathogens from entering cochlea, but when diuretics induce a transient ischemia, the barrier is temporarily disrupted allowing the entry of toxic chemicals or pathogens.

摘要

在过去二十年中,人们对袢利尿剂的耳毒性作用及潜在机制的理解取得了相当大的进展。作为袢利尿剂的典型代表,依他尼酸或呋塞米仅会导致暂时性听力损失,但很少会导致永久性耳聋,除非用于严重的急性或慢性肾衰竭或与其他耳毒性药物合用。袢利尿剂会在耳蜗中引发独特的病理变化,例如血管纹上皮中出现水肿间隙,这会导致内淋巴电位迅速下降,最终导致耳蜗微音器电位、总和电位及复合动作电位丧失。袢利尿剂会干扰血管纹中的腺苷酸环化酶和Na+/K+-ATP酶,并抑制血管纹中的Na-K-2Cl协同转运蛋白,然而最近的报告表明,最早的作用之一是消除供应外侧壁的血管中的血流。由于依他尼酸在体外不会损伤血管纹,所观察到的Na+/K+-ATP酶和Na-K-2Cl的变化可能是血管纹缺血和缺氧导致的继发效应。最近的观察表明,肾素存在于血管纹小动脉周围的周细胞中,这表明利尿剂可能通过肾素分泌和血管紧张素形成诱导局部血管收缩。血-迷路屏障中的紧密连接可防止有毒分子和病原体进入耳蜗,但当利尿剂引发短暂性缺血时,该屏障会暂时被破坏,从而使有毒化学物质或病原体得以进入。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4f/6002634/ddcb7dc379fd/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验